EMEA-000249-PIP01-10
Key facts
| Invented name |
Fluenz
|
| Active substance |
Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/14/2011
|
| PIP number |
EMEA-000249-PIP01-10
|
| Pharmaceutical form(s) |
Nasal spray suspension
|
| Condition(s) / indication(s) |
Prevention of influenza infection
|
| Route(s) of administration |
Intranasal use
|
| Contact for public enquiries |
MedImmune, LLC
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|